From early therapy to newer formulations
Growth hormone treatment has changed substantially as manufactured somatropin and delivery devices have developed. Researchers have also studied longer-acting formulations. Different formulations cannot be assumed equivalent for an individual patient.
Choosing treatment
Availability, indication, device, monitoring requirements and a person's medical history all matter. A licensed provider determines whether treatment is appropriate and which product to prescribe; this site does not make that decision.
This article is for general information, not individual medical advice. Discuss indications, risks, monitoring and alternatives with a licensed provider. An evaluation does not guarantee a prescription.
← Back to all articles